• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植术前终末期肾病患者肾细胞癌的患病率:一项病理分析。

Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis.

作者信息

Denton Mark D, Magee Colm C, Ovuworie Cyril, Mauiyyedi Shamila, Pascual Manuel, Colvin Robert B, Cosimi A Benedict, Tolkoff-Rubin Nina

机构信息

Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.

出版信息

Kidney Int. 2002 Jun;61(6):2201-9. doi: 10.1046/j.1523-1755.2002.00374.x.

DOI:10.1046/j.1523-1755.2002.00374.x
PMID:12028461
Abstract

BACKGROUND

Acquired renal cystic disease (ARCD), renal adenoma (AD), and renal cell carcinoma (RCC) are more common in patients with end-stage renal disease (ESRD). However, the prevalence of these conditions in patients undergoing transplantation, and the clinical characteristics associated with their occurrence are unclear.

METHODS

At our institution, the majority of patients undergo an ipsilateral native nephrectomy at the time of transplantation, providing a unique opportunity to study the prevalence and pathology of ARCD, AD and RCC in ESRD. We retrospectively reviewed all consecutive nephrectomy pathology reports over a six year period. Demographic and clinical characteristics associated with these lesions were identified.

RESULTS

Two hundred and sixty nephrectomy reports were reviewed: ARCD, AD, RCC and oncocytoma were found in 33%, 14%, 4.2% and 0.6% of cases, respectively. On multivariable analysis, ARCD was positively associated with male sex and longer dialysis duration and negatively associated with peritoneal dialysis. Similarly, AD was positively associated with male sex, longer dialysis duration and greater age. There was a trend for RCC cases to share similar associations although the small total number of cases precluded findings of statistical significance.

CONCLUSION

By pathologic analysis, renal tumors are more common in the pre-transplant ESRD population than previously reported (using radiologic methods). Our study also identifies risk factors for their occurrence. This may prove useful in designing screening studies for renal tumors in this patient population.

摘要

背景

获得性肾囊肿疾病(ARCD)、肾腺瘤(AD)和肾细胞癌(RCC)在终末期肾病(ESRD)患者中更为常见。然而,这些疾病在接受移植患者中的患病率以及与其发生相关的临床特征尚不清楚。

方法

在我们机构,大多数患者在移植时接受同侧自体肾切除术,这为研究ESRD中ARCD、AD和RCC的患病率及病理提供了独特机会。我们回顾性分析了六年期间所有连续的肾切除病理报告。确定了与这些病变相关的人口统计学和临床特征。

结果

共回顾了260份肾切除报告:分别在33%、14%、4.2%和0.6%的病例中发现了ARCD、AD、RCC和嗜酸细胞瘤。多变量分析显示,ARCD与男性、透析时间延长呈正相关,与腹膜透析呈负相关。同样,AD与男性、透析时间延长和年龄较大呈正相关。RCC病例有类似的相关趋势,尽管病例总数较少,无法得出具有统计学意义的结果。

结论

通过病理分析,移植前ESRD人群中的肾肿瘤比以前报道的(使用放射学方法)更为常见。我们的研究还确定了其发生的危险因素。这可能有助于设计针对该患者群体肾肿瘤的筛查研究。

相似文献

1
Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis.肾移植术前终末期肾病患者肾细胞癌的患病率:一项病理分析。
Kidney Int. 2002 Jun;61(6):2201-9. doi: 10.1046/j.1523-1755.2002.00374.x.
2
Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?透析和移植患者的原肾发生的肾细胞癌(RCC):它们是不同的实体吗?
BJU Int. 2012 Dec;110(11 Pt B):E570-3. doi: 10.1111/j.1464-410X.2012.11273.x. Epub 2012 Jun 22.
3
Renal cell carcinoma and end stage renal disease.肾细胞癌与终末期肾病
J Urol. 2006 Jun;175(6):2018-20; discussion 2021. doi: 10.1016/S0022-5347(06)00340-5.
4
Renal cell carcinoma in patients with end-stage renal disease has favorable overall prognosis.终末期肾病患者的肾细胞癌总体预后良好。
Clin Transplant. 2014 Feb;28(2):211-6. doi: 10.1111/ctr.12299.
5
Acquired cystic disease-associated renal cell carcinoma is the most common subtype in long-term dialyzed patients: Central pathology results according to the 2016 WHO classification in a multi-institutional study.获得性囊性疾病相关性肾细胞癌是长期透析患者中最常见的亚型:多机构研究中根据2016年世界卫生组织分类的中心病理学结果。
Pathol Int. 2018 Oct;68(10):543-549. doi: 10.1111/pin.12718. Epub 2018 Sep 6.
6
Renal cell carcinoma in dialysis patients: a single center experience.透析患者中的肾细胞癌:单中心经验
Int J Urol. 2006 Aug;13(8):1045-8. doi: 10.1111/j.1442-2042.2006.01498.x.
7
Renal cell carcinoma in patients with end-stage renal disease: relationship between histological type and duration of dialysis.终末期肾病患者的肾细胞癌:组织学类型与透析时间的关系。
BJU Int. 2010 Mar;105(5):620-7. doi: 10.1111/j.1464-410X.2009.08817.x. Epub 2009 Aug 28.
8
Renal Cell Carcinoma in Kidney Transplant Candidates.肾移植候选者中的肾细胞癌
Transplant Proc. 2017 Jul-Aug;49(6):1312-1317. doi: 10.1016/j.transproceed.2017.01.087.
9
Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.与普通人群中的肾细胞癌(RCC)相比,终末期肾病患者的 RCC 具有许多有利的临床、病理和预后特征。
Eur Urol. 2011 Aug;60(2):366-73. doi: 10.1016/j.eururo.2011.02.035. Epub 2011 Mar 2.
10
Renal cell carcinoma in peritoneal dialysis patients.腹膜透析患者的肾细胞癌
Int Urol Nephrol. 2003;35(2):263-5. doi: 10.1023/b:urol.0000020355.30870.3a.

引用本文的文献

1
From acute tubular injury to tubular repair and chronic kidney diseases - KIM-1 as a promising biomarker for predicting renal tubular pathology.从急性肾小管损伤到肾小管修复及慢性肾脏病——KIM-1作为预测肾小管病理的一种有前景的生物标志物
Curr Res Physiol. 2025 Jun 13;8:100152. doi: 10.1016/j.crphys.2025.100152. eCollection 2025.
2
Surgical Management of Renal Cell Carcinoma in Transplanted Kidneys-A Narrative Review.移植肾肾细胞癌的外科治疗——一项叙述性综述
Cancers (Basel). 2025 May 31;17(11):1864. doi: 10.3390/cancers17111864.
3
Autosomal Dominant Polycystic Kidney Disease-Related Multifocal Renal Cell Carcinoma: A Narrative Iconographic Review.
常染色体显性多囊肾病相关多灶性肾细胞癌:一项叙述性影像学综述
Int J Mol Sci. 2025 Apr 23;26(9):3965. doi: 10.3390/ijms26093965.
4
A Case of Acquired Cystic Kidney Disease From Chronic Renal Failure Without Dialysis.一例未经透析的慢性肾衰竭所致获得性肾囊肿病病例
Cureus. 2024 Sep 28;16(9):e70396. doi: 10.7759/cureus.70396. eCollection 2024 Sep.
5
Incidental renal cell carcinoma post bilateral nephrectomy in autosomal dominant polycystic kidney disease.常染色体显性多囊肾病双侧肾切除术后的偶然发现的肾细胞癌
World J Clin Cases. 2024 Oct 6;12(28):6187-6194. doi: 10.12998/wjcc.v12.i28.6187.
6
Concomitant Wilms tumor and autosomal dominant polycystic kidney disease.伴发的肾母细胞瘤和常染色体显性多囊肾病。
Pediatr Blood Cancer. 2024 Oct;71(10):e31230. doi: 10.1002/pbc.31230. Epub 2024 Jul 31.
7
Efficacy of F-Fluorodeoxyglucose positron emission tomography/computed tomography for detecting renal cell carcinoma in patients with end-stage renal disease.F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描对终末期肾病患者肾细胞癌的检测效能。
Jpn J Radiol. 2024 Oct;42(10):1178-1186. doi: 10.1007/s11604-024-01593-5. Epub 2024 May 25.
8
Incidental finding of acquired cystic kidney disease associated renal cell carcinoma in an adolescent with kidney failure.青少年肾衰竭患者偶然发现获得性囊性肾病相关肾细胞癌。
Pediatr Nephrol. 2024 Sep;39(9):2641-2643. doi: 10.1007/s00467-024-06364-y. Epub 2024 Apr 10.
9
Acquired cystic disease-associated renal cell carcinoma with PTCH1 mutation: a case report.伴有PTCH1突变的获得性囊性疾病相关性肾细胞癌:一例报告
Front Oncol. 2024 Feb 2;14:1349610. doi: 10.3389/fonc.2024.1349610. eCollection 2024.
10
Prevalence of Renal Neoplasia in Autosomal Dominant Polycystic Kidney Disease: Systematic Review and Meta-Analysis.常染色体显性遗传多囊肾病中肾肿瘤的患病率:系统评价和荟萃分析。
Nephron. 2024;148(7):457-467. doi: 10.1159/000536245. Epub 2024 Feb 1.